TrialThe international journal of neuropsychopharmacology2022

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis.

Javier Vázquez-Bourgon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.